User profiles for Alexander G. Mathioudakis

Alexander G. Mathioudakis

NIHR Clinical Lecturer in Respiratory Medicine, The University of Manchester
Verified email at manchester.ac.uk
Cited by 8651

[HTML][HTML] The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis

…, HH Kyu, J Lam, G Lopes, AG Mathioudakis… - The Lancet Public …, 2022 - thelancet.com
Background Antimicrobial resistance (AMR) represents one of the most crucial threats to
public health and modern health care. Previous studies have identified challenges with …

ERS clinical practice guidelines on treatment of sarcoidosis

…, D Valeyre, P Korsten, AG Mathioudakis… - European …, 2021 - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on which …

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits

AG Mathioudakis, W Janssens, P Sivapalan… - Thorax, 2020 - thorax.bmj.com
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with
a significant mortality, health and economic burden. Their diagnosis, assessment and …

Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey

AG Mathioudakis, M Ghrew, A Ustianowski, S Ahmad… - Life, 2021 - mdpi.com
An online survey was conducted to compare the safety, tolerability and reactogenicity of
available COVID-19 vaccines in different recipient groups. This survey was launched in …

Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe

CI Vardavas, AG Mathioudakis… - European …, 2022 - Eur Respiratory Soc
Background As mortality from coronavirus disease 2019 (COVID-19) is strongly age-dependent,
we aimed to identify population subgroups at an elevated risk for adverse outcomes …

The need for clean air: the way air pollution and climate change affect allergic rhinitis and asthma

I Eguiluz‐Gracia, AG Mathioudakis, S Bartel… - Allergy, 2020 - Wiley Online Library
Air pollution and climate change have a significant impact on human health and well‐being
and contribute to the onset and aggravation of allergic rhinitis and asthma among other …

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis

AG Mathioudakis… - European …, 2017 - Eur Respiratory Soc
Challenges in the differentiation of the aetiology of acute exacerbations of chronic obstructive
pulmonary disease (AECOPD) have led to significant overuse of antibiotics. Serum …

Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study …

…, A Majeed, KC Makris, AG Mathioudakis… - The Lancet Child & …, 2022 - thelancet.com
Background Disability and mortality burden of non-communicable diseases (NCDs) have
risen worldwide; however, the NCD burden among adolescents remains poorly described in …

Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden

…, AG Mathioudakis, W Phipatanakul, G Wong… - The Journal of Allergy …, 2020 - Elsevier
Background It is unclear whether asthma may affect susceptibility or severity of coronavirus
disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have …

ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

AG Mathioudakis, F Abroug, A Agusti… - European …, 2022 - Eur Respiratory Soc
Clinical trials evaluating the management of acute exacerbations of COPD assess heterogeneous
outcomes, often omitting those that are clinically relevant or more important to patients…